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Abstract
Background: Acute diarrhea is one of the most serious problems in global public health that causes considerable
morbidity and mortality worldwide. Human caliciviruses (HuCV) including norovirus (NoV, genogroup GI and GII)
and sapovirus (SaV), is a leading cause of acute sporadic diarrhea in individuals across all age groups. However, few
studies had been conducted clarifying the characteristics of HuCV in diarrhea cases across all age groups in China.
Our study was aimed at assessing the HuCV-related diarrhea burden and NoV genotypes distribution in southwest
China.
Methods: The study was conducted in four hospitals in Kunming city, Yunnan province, from June 2014 to July 2015.
Stool specimens were collected from 1,121 diarrhea cases and 319 healthy controls in outpatient departments. Reverse
transcription polymerase chain reaction (RT-PCR) was used to detect NoV (GI, GII) and SaV. Sequencing was applied to
confirm the three viral infections and phylogenetic analysis was performed to determine their genotypes. A structured
questionnaire was used to record the demographic information and clinical symptoms of subjects.
Results: HuCV was detected at an 11.0 % infection rate in 1,121 diarrhea cases and at 3.4 % rate in 319 non-diarrhea
subjects (p < 0.0001, OR = 3.5, 95 % CI 1.8–6.5). The prevalence of the NoV genogroup GII and genotype GII.4 in
diarrhea cases was significantly higher than that found in healthy controls (p < 0.0001, p = 0.018, respectively).
NoV GII (n = 118, 10.5 %) was the most common HuCV subtype in diarrhea cases, followed by SaV (n = 3, 0.3 %)
and NoV GI (n = 2, 0.2 %). Of 118 NoV GII strains isolated from diarrhea patients. GII.4 (n = 55, 46.6 %) was the
predominant strain, followed by GII.3 (n = 28, 23.7 %), GII.12 (n = 25, 21.2 %), GII.17 (n = 8, 6.8 %), and GII.5 (n = 2, 1.7 %).
Of the 55 GII.4 strains, the GII.4 Sydney 2012 variant had absolutely predominant prevalence (n = 52, 94.5 %), followed
by the NoV GII.4-2006b variant (n = 3, 5.5 %). The GII.4 Orleans 2009 variant was not found in diarrhea cases of the
study.
Conclusions: NoV GII was the major genogroup and GII.4 was the most predominant strain detected in diarrhea
patients. The GII.17 is an emergent variant in sporadic diarrhea and might become the predominant strain in diarrhea
cases in the near future. Rapid, accurate detection kits need to be developed to help us find and treat NoV-associated
diarrhea in clinical settings in a timely manner.
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Background
Acute gastroenteritis is still one of the most concerning
public health problems that causes considerable morbid-
ity and mortality worldwide [1, 2]. Human caliciviruses
(HuCV) including norovirus (NoV) and sapovirus (SaV)
are single-stranded RNA viruses [3]. NoV is classified
into six genogroups (GI–GVI), which are subdivided into
at least 38 genotypes based on their cap and pol genes [4].
NoV is the leading cause of sporadic cases and outbreaks
of acute diarrhea worldwide [5, 6]. NoV-related viral
gastroenteritis, known as the stomach flu, is one kind of
mild diarrhea, and is characterized by sudden intense
vomiting (more common in children), watery stool, or li-
quid stool without blood (more common in adults) [7].
The NoV infection is self-limiting and the symptoms may
disappear after less than three days, but prolonged diar-
rhea symptoms (e.g. dehydration and death) and viral
shedding might occur in immune-deficient individuals
and the elderly [5, 8].
NoV is one of the important enteropathogens associ-
ated with acute diarrhea, but it has been underestimated
in terms of its burden for many years, for a lack of ad-
equate diagnostic tools until 1993 [8]. Although NoV
had not been cultivated with cells until now, modern
biotechnology, including gene sequencing, reverse tran-
scription polymerase chain reaction (RT-PCR), and real
time RT-PCR have been applied to detect NoV in fecal
specimens. These can help us to accurately understand
and estimate the impact of NoV [8, 9].
The prevalence of NoV is about 18.0 % in acute spor-
adic diarrhea cases worldwide [10]. The detection rates
of NoV were fluctuant in different medical facilities, and
the prevalence of NoV in community cases (24.0 %) is
higher than that of outpatient cases (20.0 %) and in-
patient cases (17.0 %), respectively [10]. Simultaneously,
NoV had a high prevalence in the Eastern Mediterranean,
and Middle and South American regions [11]. NoV-
associated diarrhea prevalence is up to 40–640 cases per
10,000 persons in outpatient treatment and 14 per 10,000
persons in emergency department visits in some de-
veloped regions [12]. NoV lead more than 21 million
sporadic diarrhea cases, over 70 thousands sporadic
hospitalization cases, and nearly 150 deaths of all ages,
in the United States annually [13, 14]. In addition,
economic loss caused by NoV was also serious; more
than $284 million in medical charges are induced by NoV
infection in emergency departments annually [12].
NoV is also known as one of the major leading causes of
acute nonbacterial outbreaks of diarrhea. NoV-associated
diarrhea outbreaks occurred more than 900 times during
the period of 1993–2011 [15], and involved many diarrhea
cases in a short timeframe, causing social panic and anx-
iety. Outbreaks of diarrhea episodes caused by NoV often
occurred in a variety of settings, such as ships, the army,
schools, hospitals, and elderly homes [16–19]. Children,
soldiers, and the elderly were susceptible to NoV out-
breaks [8, 20]. In developing countries, malnourished chil-
dren or infants raised without good hygienic conditions
had a high risk of suffering morbidity and mortality caused
by NoV [21].
NoV has caused increasing concern in recent years,
which has been attributed to a large number of reported
outbreaks of diarrhea and to food safety issues [13, 15].
Acute gastroenteritis is still one of the major public
health problems in China [22], with NoV playing an
important role in diarrhea, especially in adults [23].
But, overwhelmingly, diarrhea studies have mostly been
focusing on rotavirus in young children. Notably, the
epidemic characteristics of NoV in diarrhea cases across
all age groups is sparsely characterized, especially in low-
income regions such as southwest China. The information
on distribution of HuCV subtypes and NoV genotypes is
limited.
This study aims to: (i) understand the detection rate of
HuCV, (ii) grasp the NoV GII genotype distribution, and




An “acute diarrhea case” was defined as any case in
which the patient excreted stool more than three times
within a 24-hour period and in which the stool form was
not normal (e.g. loose, watery, bloody, and/or mucousy
stool). A “healthy control” was defined as any case in
which the subject was without diarrhea symptom and
other gastrointestinal diseases.
Collection of stool specimens and basic information
Four sentinel hospitals were selected for this study,
namely the First People’s Hospital of Yunnan Province,
the First Affiliated Hospital of Kunming Medical Univer-
sity, the Kunming Children’s Hospital, and Pushan Com-
munity Hospital.
Stool specimens were collected from subjects with
acute diarrhea and without diarrhea by trained doctors
or nurses. Sterilized sampling cups were used to collect
stools, the amount of fecal samples was more than 3 g
or 3 mL, each stool sample was temporarily preserved
at −20 °C and was transferred to the laboratory of the
local Center for Disease Control, and then a part of
each stool specimen was taken out and balanced to
10 % suspension with a phosphate buffer solution. RT-
PCR was applied to examine SaV, and NoV GI and GI.
A structured questionnaire was used to record the demo-
graphic information and clinical symptoms of each subject.
This study was conducted from July 2014 to June 2015.
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Viral RNA extraction
A viral nucleic acid extraction kit (Geneaid Biotech Ltd,
Taiwan, China) was applied to extract the viral nucleic
acid from each stool specimen following the manufac-
turer’s protocol. A 15 % fecal suspension was centrifuged
for 5 min at 14,000 g, 150 μL supernatant was used to
extract the three viral nucleic acids, and 50 μL extracted
RNA was obtained and stored at −70 °C prior to virus
detection.
SaV and NoV (GI, GII) detection
A two-step multiplex RT-PCR was performed to detect
SaV, and NoV GI and GII. The primes of p289/p290 tar-
get the polymerase region as previously described, this
pair of primes produces PCR products of 331 bp for SaV
and 319 bp for NoV (GI, GII) [24, 25]. The reverse tran-
scription reaction was performed using the SuperScript
II kit (Invitrogen, Carlsbad, CA, USA). The reaction
condition of cDNA synthesis was 42 °C for 90 min, and
99 °C for 5 min. Each 40 μL reaction volume consisted
of 20 μL SYBR® Premix Ex Taq™ (Takara Bio Inc, Shlga,
Japan), 2 μL cDNA template, 12 μL DNase and RNase
free water, and 1 μL of 10 μM forward primer and re-
verse primer, respectively. The thermal profile consisted
of 94 °C for 5 min, 40 cycles at 94 °C for 70s, 49 °C for
70s, and 72 °C for 1 min, followed by 72 °C for 10 min.
The PCR amplicons were analyzed in a 1 % agarose gel
electrophoresis at 120 V for 40 min and observed under
UV light after ethidium bromide staining. Positive PCR
products were kept at −70 °C, and were then sequenced
and phylogenetically analyzed.
Statistical analysis
Data analysis was performed using the Statistical Product
and Service Solutions (SPSS v19.0) software (IBM, USA).
The odds ratios (ORs) and 95 % confidence intervals
(CIs) of categorical variables were calculated using the
chi-square test or the Fisher’s exact test with two-tailed. A
value of p < 0.05 was considered to be statistically
significant.
A molecular evolutionary genetics analysis was employed
to perform the phylogenetic analysis (MEGA v5.2). A
phylogenetic tree was constructed using the neighbor-
joining method with 1,000 bootstrap replicates. Reference
strains were downloaded from GenBank.
Results
Basic information and clinical symptoms of subjects
In the present study, which was conducted from July
2014 to June 2015, 1,440 subjects including children and
adults participated. Among those, 1,121 were acute diar-
rhea patients and 319 were healthy controls. The male to
female sex ratios in diarrhea cases and healthy controls
were 1.00 and 1.01, respectively (χ2 = 0.341, p = 0.558).
The average ages of patients and healthy controls were
0.6 years and 2.3 years, respectively. The majority of the
subjects were from urban areas; 753 cases (67.2 %) and
223 (57.0 %) controls. The average frequency of diarrhea
in patients was six episodes (quartile range = 2). Various
types of clinical symptoms were observed in the diarrhea
cases. Vomiting (n = 263, 23.5 %) was the most common
clinical symptom, followed by fever (n = 136, 12.1 %) and
dehydration (n = 64, 5.7 %).
The prevalence of HuCV subtypes and NoV GII genotypes
in diarrhea cases and healthy controls
The detection rate of HuCV was 11.0 % (n = 123) in
diarrhea cases across all age groups. Among these, the
prevalence of NoV GII was 10.5 % (n = 118) in acute
gastroenteritis patients of all ages, followed by SaV
(0.3 %, n = 3) and NoV GI (0.2 %, n = 2). The prevalence
of both NoV genogroups (GI and GII) was 10.7 % (n = 120)
in diarrhea cases across all ages.
HuCV was detected in 123 (11.0 %) diarrhea cases and
11 (3.4 %) healthy controls (p < 0.0001, OR = 3.5, 95 %
CI 1.8–6.5). No significant differences were observed in
NoV GI between diarrhea patients (n = 2, 0.2 %) and
healthy controls (n = 1, 0.3 %, p = 0.528). SaV was de-
tected in three (0.3 %) diarrhea cases, but was not found
in controls (p = 0.472). NoV GII was more prevalent in
patients relative to healthy controls across all age groups
(10.5 %, 3.1 %, respectively, OR = 3.6, 95 % CI 1.8–7.0).
NoV genotype GII.4 was found in 55 (4.9 %) diarrhea
cases and six (1.9 %) non-diarrhea cases (p = 0.018,
OR = 2.7, 95 % CI 1.1–6.3). GII.12 was detected in 25
diarrhea cases and three healthy controls (2.2 %, 0.9 %,
respectively, p = 0.141, OR = 2.4, 95 % CI 0.7–8.0). The
detection rate of GII.5 in diarrhea cases was as high as in
healthy controls (0.2 %, 0.3 %, respectively, p = 0.403,
OR = 0.57, 95 % CI 0.05–6.3). No significant differences in
GII.12 and GII.5 were observed between diarrhea patients
and healthy patients (see Table 1). GII.17 was only found
in diarrhea cases (n = 8, 0.7 %).
In patients aged below five years, HuCV and NoV GII
were detected more often in those with diarrhea than in
those without (11.5 % vs. 4.7 %, respectively, p < 0.05,
OR = 2.6, 95 % CI 1.3–5.5; 11.1 % vs. 5.5 %, respectively,
p < 0.05, OR = 2.5, 95 % CI 1.2–5.3). HuCV was more
prevalent in patients than in controls aged above five
years (8.6 % vs. 1.5 %, respectively, p = 0.005, OR = 6.4,
95 % CI 1.5–27.5). NoV GII was more prevalent in patients
with diarrhea relative to healthy controls aged above five
years (8.2 % vs. 1.5 %, respectively, p = 0.01007, OR = 6.0,
95 % CI 1.4–26.2). NoV GII was detected in 14.8 % of eld-
erly cases, but neither NoV GI nor SaV was detected in
controls over 65 years. No significant differences in these
three virus pathogens were observed between cases and
controls over 65 years of age (see Table 1).
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One hundred and twenty-three strains of HuCV were
isolated from diarrhea cases of all ages. NoV GII (n = 118,
10.5 %) was the leading subtype of HuCV, followed by SaV
(n = 3, 0.3 %) and NoV GI (n = 2, 0.2 %). Of the 118 strains
of NoV GII isolated from 1,121 diarrhea cases, the pre-
dominant genotype was GII.4 (n = 55, 46.6 %), followed by
GII.3 (n = 28, 23.7 %) and GII.12 (n = 25, 21.2 %). The
prevalences of GII.17 and GII.5 were less than 1.0 % in
diarrhea cases. Among the 10 strains of NoV GII detected
in healthy controls, the top two most prevalent genotypes
were GII.12 (n = 3, 0.9 %) and GII.5 (n = 3, 0.3 %). Others
genotypes were not detected in asymptomatic individuals
(see Table 1).
The age distribution of HuCV subtypes and NoV GII
genotypes in diarrhea cases
In the present study, diarrhea cases were divided into
five subunits, where 791 (70.6 %), 59 (5.3 %), 21 (1.9 %),
223 (19.9 %), and 27 (2.4 %) diarrhea patients fell into the
age ranges of 0–2 years, 2–5 years, 5–14 years, 14–65
years, and over 65 years, respectively. Although NoV GII
was more prevalent in children below two years of age
and adults above 65 years of age, no significant difference
in presence of NoV GII was found between the age groups
(χ2 = 8.31, p = 0.061). GII.12 had an obvious age distribu-
tion trend (χ2 = 15.4, p = 0.004), which was only found in
patients aged 0–2 years (3.0 %) and 2–5 years (1.7 %).
The prevalence of GII.4 had not age distribution trend
(χ2 = 3.83, p = 0.426). No significant differences in GII.17,
GII.3, and GII.5 were observed in diarrhea cases across all
age groups (see Table 2).
The seasonal prevalence of HuCV subtypes and NoV GII
genotypes in diarrhea cases
No notable seasonal trend was observed in NoV GI and
SaV, but NoV GII (n = 39, 14.6 %) had a peak in prevalence
in the fall (χ2 = 12.2, p = 0.007). The prevalences of GII.5
and GII.12 did not show distinct seasonal variation, and the
prevalences of GII.3 and GII.17 showed minor seasonal var-
iations across one year, respectively. GII.4 was detected
throughout the year and significant differences were ob-
served in different seasons (χ2 = 13.3, p = 0.004), with a sea-
sonal peak of GII.4 (n = 23, 8.4 %) in the fall (see Table 3).
The clinical symptoms of diarrhea patients with HuCV
subtypes and NoV GII genotypes
The various clinical symptoms associated with HuCV
subtypes and NoV genotypes are summarized in Table 4.
Table 1 HuCV infection detected in the stool samples of patients with diarrhea and healthy controls in Kunming, China (age stratified)
Age group Subtypes/genotypes Diarrhea Control p-value OR (95 % CI)
N (%) N (%)
All age groups Cases = 1,121 Controls = 319 HuCV 123 (11.0) 11 (3.4) <0.0001 3.5 (1.8–6.5)
NoV GII 118 (10.5) 10 (3.1) <0.0001 3.6 (1.8–7.0)
NoV GI 2 (0.2) 1 (0.3) 0.528
SaV 3 (0.3) 0 (0.0) 0.472
GII.4 55 (4.9) 6 (1.9) 0.018 2.7 (1.1–6.3)
GII.3 28 (2.5) 0 (0.0) 0.001
GII.12 25 (2.2) 3 (0.9) 0.141 2.4 (0.7–8.0)
GII.17 8 (0.7) 0 (0.0) 0.134
GII.5 2 (0.2) 1 (0.3) 0.403 0.57 (0.05–6.3)
0–5 years Cases = 850 Controls = 170 HuCV 98 (11.5) 8 (4.7) 0.008 2.6 (1.3–5.5)
NoV GII 94 (11.1) 8 (5.5) 0.012 2.5 (1.2–5.3)
NoV GI 1 (0.1) 0 (0.0) 0.833
SaV 3 (0.4) 0 (0.0) 0.578
5–65 years Cases = 244 Controls = 137 HuCV 21 (8.6) 2 (1.5) 0.005 6.4 (1.5–27.5)
NoV GII 20 (8.2) 2 (1.5) 0.007 6.0 (1.4–26.2)
NoV GI 1 (0.4) 0 (0.0) 0.640
SaV 0 (0.0) 0 (0.0)
≥65 years Cases = 27 Controls = 12 HuCV 4 (14.8) 1 (8.3) 0.357 1.9 (0.2–19.2)
NoV GII 4 (14.8) 0 (0.0) 0.213
NoV GI 0 (0.0) 1 (8.3) 0.308
SaV 0 (0.0) 0 (0.0)
Significant difference are marked in bold
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In acute diarrhea cases; vomiting was observed more
frequently in diarrhea cases infected with GII.4 (40.0 %,
p < 0.05), GII.3 (57.1 %, p < 0.05), and GII.12 (48.0 %,
p < 0.05); and dehydration was only associated with
GII.4 (14.5 %, p < 0.05) and GII.3 (25 %, p < 0.05). Watery
stool was more commonly observed in diarrhea patients
infected with GII.4, GII.3, and GII.12 (63.6 %, 75.0 %,
72.0 %, respectively, p < 0.05); and mucousy stool was
found less frequently in GII.3 and GII.12 (25.0 %, 24.0 %,
respectively, p < 0.05) than in GII.4 (see Table 4).
Distribution of NoV GII genotypes
In the study, 123 strains of HuCV were isolated from
acute gastroenteritis cases, of which two (1.6 %) cases
were NoV GI, three (2.4 %) cases were classified as SaV,
and 118 (95.9 %) cases were classified as NoV GII.
Among the 118 strains of NoV GII, five genotypes were
identified as followed: GII.4 (n = 55, 46.6 %), GII.3 (n = 28,
23.7 %), GII.12 (n = 25, 21.2 %), GII.17 (n = 8, 6.8 %), and
GII.5 (n = 2, 1.7 %). Of all the 55 strains of GII.4, the GII.4
Sydney 2012 variant was absolutely predominant (n = 52,
94.5 %), followed by the GII.4-2006b variant (n = 3, 5.5 %).
The GII.4 Orleans 2009 variant was not found in diarrhea
cases in this study.
Eleven strains of HuCV were found in healthy con-
trols. One (9.1 %) case was classified as NoV GI, which
was a GI.3 genotype, and 10 (90.9 %) cases were classi-
fied as NoV GII, which were divided into GII.4 (n = 6,
60.0 %), GII.12 (n = 3, 30.0 %), and GII.5 (n = 1, 10.0 %).
Of the six strains of GII.4, four (80.0 %) strains were of
the GII.4 Sydney 2012 variant and two (20.0 %) were of
the GII.4-2006b variant. The GII.4 Orleans 2009 variant
was not found in healthy controls (see Fig. 1).
Discussion
Acute diarrhea is still a serious public health problem,
and is the second leading cause of morbidity and mortality
among children below five years of age worldwide [1, 2].
NoV is one of the major enteropathogen causes of spor-
adic diarrhea in all age groups [10]. In China, most studies
of acute gastroenteritis including HuCV infection have
focused on children below five years of age [22, 26].
Few studies have been conducted to clarify the HuCV
epidemiological characteristics in children and adults
Table 3 Seasonal distribution of HuCV subtypes and GII genotypes in diarrhea cases













HuCV 22 (8.2) 28 (14.0) 41 (15.8) 32 (8.1) 0.005
NoV GI 1 (0.4) 0 (0.0) 1 (0.4) 0 (0.0) 0.388
SaV 1 (0.4) 1 (0.5) 1 (0.4) 0 (0.0) 0.448
NoV GII 20 (7.5) 27 (13.5) 39 (14.6) 32 (8.1) 0.007
GII.4 8 (3.0) 12 (6.0) 23 (8.4) 12 (3.0) 0.004
GII.3 6 (2.4) 7 (3.5) 4 (1.5) 11 (2.8) 0.557
GII.12 4 (1.5) 5 (2.5) 11 (4.2) 5 (1.3) 0.087
GII.17 1 (0.4) 3 (1.5) 1 (0.4) 3 (0.7) 0.505
GII.5 1 (0.4) 0 (0.0) 0 (0.0) 1 (0.3) 0.554
Significant differences are marked in bold
Table 2 The prevalence of HuCV subtypes and NoV GII genotypes in diarrhea cases, by age group



















HuCV 123 (11.0) 94 (11.9) 4 (6.8) 2 (9.5) 19 (8.5) 4 (14.8) 0.178
NoV GI 2 (0.2) 0 (0.0) 1 (1.7) 0 (0.0) 1 (0.4) 0 (0.0) 0.193
SaV 3 (0.3) 2 (0.3) 1 (1.7) 0 (0.0) 0 (0.0) 0 (0.0) 0.489
NoV GII 118 (10.5) 92 (11.6) 2 (3.4) 2 (9.5) 18 (8.7) 4 (14.8) 0.063
GII.4 55 (4.9) 42 (5.3) 1 (1.7) 2 (9.5) 9 (4.0) 1 (3.7) 0.426
GII.3 28 (2.5) 20 (2.5) 0 (0.0) 0 (0.0) 6 (2.7) 2 (7.4) 0.154
GII.12 25 (2.2) 24 (3.0) 1 (1.7) 0 (0.0) 0 (0.0) 0 (0.0) 0.004
GII.17 8 (0.7) 5 (0.6) 0 (0.0) 0 (0.0) 2 (0.9) 1 (3.7) 0.503
GII.5 2 (0.2) 1 (0.1) 0 (0.0) 0 (0.0) 1 (0.5) 0 (0.0) 0.901
Significant differences are marked in bold
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[27, 28], especially in developing regions [26]. This
study provided new data on acute diarrhea cases in-
fected with HuCV in Yunnan Province, China. The
present study described the detection rate, epidemio-
logical characteristics of HuCV subtypes, and genetic
diversity of NoV genotypes.
In this study, NoV GII was the most common genogroup
detected among diarrhea cases and healthy controls, and
GII.4 was the most prevalent genotype. The GII.4 Sydney
2012 variant was still the most prevalent one both in pa-
tients and controls of all ages. Although the GII.17 geno-
type emerged at the end of 2014 and was most prevalent in
outbreaks of diarrhea in some Asian countries and the
United States [29–33], the GII.17 variant did not replace
the GII.4 Sydney 2012 variant in sporadic diarrhea cases in
the study. This finding was in accordance with other stud-
ies conducted in China [28, 34], which suggested that the
GII.4 Orleans 2009 variant did not replace the GII.4-2006b
variant and was not prevalent in China [28, 34]. The mo-
lecular epidemiology of NoV in China was that the GII.4
Sydney 2012 variant directly replaced the GII.4-2006b vari-
ant and has become the predominant variant since 2012
[34–36]. Moreover, this epidemic’s characteristics were not
accordance with findings from other studies conducted in
some European and American countries, where the
GII.4 Orleans 2009 variant has successfully replaced
the GII.4-2006b variant since 2009, and the GII.4 Syd-
ney 2012 variant has replaced the GII.4 Orleans 2009 vari-
ant since 2012 [6, 34].
In this study, NoV GII was one of the diarrhea-
associated pathogens in all age groups, but NoV GII did
not cause acute diarrhea in individuals over 65 years.
Some studies have also suggested that NoV disease risk
among older adults has decreased in upper-middle and
high-income countries [37]. Other studies showed that
NoV GII was a diarrhea-associated pathogen and the at-
tributable risk of NoV GII was located the third rank
among all enteric pathogens, which was only lower than
that of rotavirus and Shigella spp. [38]. However, other
studies showed that NoV GII was not an enteropatho-
gen associated with diarrhea [39]. This conclusion
might be attributable to selection bias in the samples
sources, which were all from pediatric emergency
departments.
NoV GII infection had relative low risk in children
under five years (seen in Table 1). Several factors may
explain this phenomenon: on the one hand, immune de-
fenses (such as milk IgA antibodies) might protect against
NoV GII infection in children below six months of age
[40, 41]; on the other hand, non-specific properties
(such lactoferrin and enterotoxin-binding oligosaccharides
present in artificial milk powder, which is the most com-
mon food for children) might prevent the adherence of
NoV GII to mucosal invasion to reduce the virus count or
toxicity [40, 42]. These factors might also interpreted that
the healthy carrier rate of NoV GII in non-diarrhea sub-
jects below five years of age (5.5 %) was higher than that
of healthy controls above five years of age (1.5 %). Math-
ematical modeling also proved that protection against
acute diarrhea could be acquired in early life and led more
frequently to NoV asymptomatic infection [43].
The study showed that NoV GII was the prominent
HuCV subtype, but NoV GI and SaV were rarely found
in diarrhea patients. The composition of these three vi-
ruses was similar to results from other studies, which
showed that NoV GII accounted for more than 90 % of
all HuCV-positive cases in China [34]. In this study,
GII.4 was preponderant genotype in all genotypes of NoV
GII, which was in accordance with the epidemic character-
istics of GII.4 in other studies [44], but the constituent ra-
tio of GII.4 in all NoV GII genotypes was less than that
found in other studies conducted in the period of 2008–
2009 in China [28]. The reason for this might be that
GII.4 was prevalent for several years, while the GII.17 has
been emergent and prevalent only since 2014 [29].
The prevalence of NoV was 10.7 % in acute gastro-
enteritis in patients of all ages in this study, which was
lower than the global detection rate (18.0 %), but was
close to the prevalence in high-mortality countries
(14.0 %) [45]. The low prevalence of NoV might suggest
that other enteropathogens such as bacterial and parasitic
pathogens played a prominent role in diarrhea disease
Table 4 Clinical characteristics of acute diarrhea cases infected with NoV GII genotypes
Symptom GII.4 GII.3 GII.12 GII.17
n = 55 n = 28 n = 25 n = 8
N (%) p-value N (%) p-value N (%) p-value N (%) p-value
Fever (>37.3 °C) 10 (18.2) 0.174 2 (7.1) 0.581 3 (12.0) 1.000 0 (0.0) 0.606
Vomiting 22 (40.0) <0.05 16 (57.1) <0.05 12 (48.0) <0.05 2 (25.0) <0.05
Dehydration 8 (14.5) <0.05 7 (25.0) <0.05 3 (12.0) 0.35 1 (12.5) 0.376
Watery stool 35 (63.6) <0.05 21 (75.0) <0.05 18 (72.0) <0.05 5 (62.5) 0.481
Mucousy stool 17 (30.9) 0.400 7 (25.0) <0.05 6 (24.0) <0.05 3 (37.5) 0.727
Other stool 3 (5.0) 1.000 0 (0.0) 0.372 1 (4.0) 1.000 0 (0.0) 1.000
Significant differences are marked in bold
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[10]. Acute gastroenteritis cases due to NoV had mild
diarrhea symptoms, thus many NoV-related diarrhea cases
might not seek medical treatment. This might explain why
the prevalence of NoV in community cases (24.0 %) was
higher than that found in outpatient cases (17.0 %) [10].
Diarrhea cases in our study were all selected from out-
patient departments, which might be the reason for the
low prevalence of NoV in this study. The prevalence of
NoV in this study was lower than that found in Shanghai,
China [27]. This difference might be caused by the dif-
ferent food habits among residents in different areas;
shellfish, which is easily infected with NoV [46], was
one of the common foods for residents in Shanghai,
which is near the Yangtze river and the sea, but shellfish is
not commonly eaten in inland regions. Food species might
be one of the important reasons for the variation of NoV
in different regions.
There were no significant differences in NoV GII
prevalence across several age groups, which might sug-
gest that age had no significant influence on NoV infec-
tion. Other studies led to similar conclusions [28, 34].
The reasons might be that NoV had great diversity and
a lack of long-term immunity, hence human immunity
to NoV was not stable and repeated infection might
occur throughout life [8]. But the prevalence of GII was
slightly higher in children aged below five years with
diarrhea and in elderly patients. This finding was in ac-
cordance with some other reports [43, 47]. NoV tended
to infect these subgroups because they have relatively
low immunity to NoV [20]. One interesting finding of
this study was that diarrhea cases in children below two
years of age and elderly patients were susceptible to the
GII.17 genotype, which might be explained by the weak
immune system of these two age groups and the fact
that the newly emergent GII.17 had no immune barrier
among the population.
In this study, the GII.17 variant emerged in diarrhea
patients. This finding was in accordance with other stud-
ies. The GII.17 variant was the prominent genotype in
sporadic diarrhea patients, the detection rate of which in
diarrhea cases was up to 15.0 %, which was higher than
the prevalence of the GII.4 Sydney 2012 strain in sporadic
diarrhea patients in Jiangsu Province, China, from the end
of 2014 onwards [29]. The novel pathogen GII.17 variant
Fig. 1 Phylogenetic trees of SaV and NoV (GI, GII) based on
dependent RNA polymerase. ●: diarrhea cases above five years of
age; ○: controls above five years of age; ▲: diarrhea cases below
five years of age; △: controls below five years of age. The count in
bracket is the number of same genotype isolated from diarrhea
cases and healthy controls. The molecular analysis of SaV and NoV
(GI, GII) showed that NoV GII was the major subtype of HuCV, and
GII.4 was the most predominant genogroup detected in diarrhea
patients. In addition, GII.17 variant emerged in diarrhea cases
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was found in diarrhea patients in the study, which benefit-
ted from the web-based information system for disease
control and prevention in China [48]. In addition,
laboratory-based pathogen diagnosis was conducted to
find novel pathogens or variant strains [49, 50]. In the
meantime, a syndrome-based surveillance system has
also been important in supporting the detection of vari-
ations in the intestinal pathogen spectrum and the
emergence of the new pathogen or variant strain in
China [50, 51].
Limitations of this study
There were several limitations on our research. Firstly,
the subjects were mainly selected from urban areas, and
in addition, the diarrhea cases were all selected from
outpatient department, which might lead to selection
bias in respect of the epidemiological characteristics of
HuCV. Secondly, the number of healthy controls was
small, hence the OR of the HuCV and NoV genogroups
were not highly reliable. Thirdly, genetic characterization
of NoV was only based on partial polymerase regions in
this study. However, the genotyping of NoV based on
only capsid regions or on both regions might provide
different results. Therefore, further study involving diarrhea
cases selected from urban, rural, outpatient, and inpatients
departments will should be conducted to ensure accurate
assessment of the NoV disease burden. A 1:1 match case-
control study will be a good choice. Meanwhile, genotyping
of NoV based on both capsid regions and RNA-dependent
RNA polymerase regions should be conducted in order
to enhance the accuracy and effectiveness of NoV GII
genotyping.
Conclusions
In summary, the results show that NoV is one of the
major causes of diarrhea, that GII.4 is still the predominant
strain, and that GII.17 has emerged in sporadic diarrhea
cases and might become a predominant strain, which will
lead to more cases and outbreaks of diarrhea in the near fu-
ture. This will provide new obstacles to preventing NoV-
associated diarrhea. Therefore, monitoring the prevalence
trends and evolution of GII.17 is necessary.
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